Cardio-cerebral infarction refers to the simultaneous occurrence of acute ischaemic stroke and myocardial infarction, a rare but life-threatening syndrome that unites two leading causes of mortality ...
Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released classification system presents a four-stage classification of heart attack ...
Myocardial infarction (MI) causes millions of deaths worldwide. Though there have been advances in the survival rates following ST-elevation MI (STEMI), survivors often develop heart failure due to ...
Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification of Acute Myocardial Infarction ...
The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic ...
Cardiogenic shock is characterized by depression of cardiac function that leads to low blood pressure, coronary ischemia, and further decreased cardiac contractility resulting in tissue hypoxemia. The ...
Philadelphia, October 31, 2023 – Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification ...
The primary end point event (composite of death from CV causes, myocardial infarction, or stroke) occurred in 12.2 and 13.1% in the tirzepatide and dulaglutide groups, respectively. HealthDay News — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results